Rockland Trust’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$66.6M Sell
458,433
-31,616
-6% -$4.37M 2.55% 9
2026
Q2
$63M Sell
490,049
-44,914
-8% -$5.26M 2.47% 9
2026
Q1
$64.4M Sell
534,963
-42,467
-7% -$4.9M 2.58% 8
2025
Q4
$60.8M Sell
577,430
-2,909
-0.5% -$273K 2.39% 8
2025
Q3
$48.7M Buy
580,339
+24,300
+4% +$2M 2% 10
2025
Q2
$43.6M Buy
550,278
+57,044
+12% +$4.53M 2.12% 10
2025
Q1
$44.3M Buy
493,234
+76,223
+18% +$7.12M 2.23% 10
2024
Q4
$41.5M Buy
417,011
+30,562
+8% +$3.15M 2.11% 11
2024
Q3
$43.9M Sell
386,449
-14,917
-4% -$1.77M 2.16% 11
2024
Q2
$49.7M Sell
401,366
-6,299
-2% -$811K 2.62% 7
2024
Q1
$53.8M Sell
407,665
-814
-0.2% -$100K 2.83% 6
2023
Q4
$44.5M Buy
408,479
+11,868
+3% +$1.23M 2.44% 8
2023
Q3
$40.8M Buy
396,611
+23,808
+6% +$2.57M 2.46% 8
2023
Q2
$43M Sell
372,803
-36,018
-9% -$4.09M 2.57% 8
2023
Q1
$43.5M Sell
408,821
-1,628
-0.4% -$176K 2.73% 6
2022
Q4
$45.5M Sell
410,449
-9,567
-2% -$978K 2.89% 5
2022
Q3
$36.2M Buy
420,016
+4,214
+1% +$376K 2.58% 7
2022
Q2
$37.9M Buy
415,802
+4,458
+1% +$395K 2.62% 6
2022
Q1
$33.8M Buy
411,344
+34,038
+9% +$2.68M 2.15% 10
2021
Q4
$28.9M Buy
377,306
+15,836
+4% +$1.26M 1.84% 13
2021
Q3
$27.2M Buy
361,470
+76,373
+27% +$5.81M 1.89% 12
2021
Q2
$22.2M Buy
285,097
+152,982
+116% +$11.4M 1.53% 18
2021
Q1
$10.2M Buy
132,115
+13,485
+11% +$1.04M 0.73% 48
2020
Q4
$9.7M Buy
118,630
+12,887
+12% +$1.03M 0.75% 46
2020
Q3
$8.77M Sell
105,743
-1,355
-1% -$111K 0.75% 47
2020
Q2
$8.28M Sell
107,098
-1,030
-1% -$81.3K 0.74% 47
2020
Q1
$8.32M Buy
108,128
+3,884
+4% +$320K 0.85% 45
2019
Q4
$9.48M Sell
104,244
-3,266
-3% -$281K 0.78% 46
2019
Q3
$8.9M Buy
107,510
+33,975
+46% +$2.85M 0.81% 45
2019
Q2
$6.17M Buy
73,535
+1,337
+2% +$107K 0.61% 57
2019
Q1
$6M Buy
72,198
+9,573
+15% +$750K 0.64% 57
2018
Q4
$4.78M Sell
62,625
-2,047
-3% -$151K 0.59% 53
2018
Q3
$4.59M Sell
64,672
-385
-0.6% -$25.7K 0.56% 53
2018
Q2
$3.95M Sell
65,057
-558
-0.9% -$33K 0.51% 57
2018
Q1
$3.57M Buy
65,615
+2,340
+4% +$132K 0.47% 59
2017
Q4
$3.56M Buy
63,275
+2,015
+3% +$117K 0.46% 61
2017
Q3
$3.92M Buy
61,260
+2,445
+4% +$155K 0.59% 50
2017
Q2
$3.77M Buy
58,815
+2,815
+5% +$180K 0.59% 51
2017
Q1
$3.56M Buy
56,000
+176
+0.3% +$11.2K 0.56% 53
2016
Q4
$3.29M Sell
55,824
-136
-0.2% -$8.34K 0.53% 55
2016
Q3
$3.49M Sell
55,960
-261
-0.5% -$16K 0.61% 50
2016
Q2
$3.24M Buy
56,221
+2,070
+4% +$115K 0.56% 51
2016
Q1
$2.86M Buy
54,151
+4,380
+9% +$225K 0.51% 53
2015
Q4
$2.63M Buy
49,771
+5,739
+13% +$303K 0.46% 55
2015
Q3
$2.18M Buy
44,032
+1,508
+4% +$84K 0.43% 56
2015
Q2
$2.42M Buy
42,524
+963
+2% +$56.6K 0.48% 47
2015
Q1
$2.39M Buy
41,561
+1,594
+4% +$94.6K 0.51% 47
2014
Q4
$2.27M Buy
39,967
+566
+1% +$33K 0.47% 48
2014
Q3
$2.34M Buy
39,401
+5,309
+16% +$312K 0.51% 44
2014
Q2
$1.97M Buy
34,092
+16,666
+96% +$953K 0.45% 45
2014
Q1
$989K Sell
17,426
-16
-0.1% -$868 0.23% 58
2013
Q4
$873K Sell
17,442
-1,379
-7% -$66.1K 0.21% 69
2013
Q3
$896K Buy
18,821
+222
+1% +$10.6K 0.24% 60
2013
Q2
$864K Hold
18,599
– – 0.24% 63

Other funds holding MRK

Rockland Trust's MRK Position: Q3 2026 in Review

Rockland Trust reduced its Merck (MRK) stake by 6.5% in Q3 2026, selling an estimated $4.37M and leaving 458,433 shares worth $66.6M. The position accounts for 2.55% of the portfolio, ranked #9.

Rockland Trust first reported a position in MRK in Q2 2013 and has held it in 54 quarters since. 3,977 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Rockland Trust held 458,433 shares of Merck worth $66.6M as of Q3 2026.
  • Rockland Trust sold 31,616 Merck shares in Q3 2026, an estimated $4.37M.
  • Merck made up 2.55% of Rockland Trust's portfolio in Q3 2026, its #9 holding.
  • Rockland Trust first reported a position in Merck in Q2 2013 and has held it in 54 quarters since.
  • 3,977 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Rockland Trust's 13F filing for Q3 2026, filed 5 Oct 2026.